Two in five preclinical studies on subarachnoid hemorrhage (SAH) published in peer-reviewed scientific journals contain ...

Only two days after Bridgebio Pharma Inc. impressed investors with data from BBP-418 in limb-girdle muscular dystrophy type ...

Medline Inc. filed a public S1 with the SEC Oct. 28, moving the IPO first signaled in December 2024 closer to reality. The Northfield, Ill.-based medical supply distributor did not disclose the number ...

With a modest $7 million up front but an ultimate payout potentially topping $1 billion on the line, Modex Therapeutics Inc.

Zag Bio Inc. came out of stealth mode with $80 million in funding so far, including a recently closed series A financing, to ...

Qyuns Therapeutics Co. Ltd. has entered into a collaboration and license agreement with F. Hoffmann-La Roche Ltd. granting ...

Australian scientists have developed a simpler, less invasive way to detect Alzheimer’s disease that could make it easier for ...

The DeGregorio Family Foundation, with support from the Esophageal Cancer Awareness Association, has awarded an additional ...

Shooting for further proof of durable, drug-free, disease-free remission with a single dose of KYV-101 in generalized ...

Exousia Pro Inc.’s subsidiary, Exousia AI, has received orphan drug designation from the FDA for its exosome-based treatment ...

Various derivatives of α-D-tocopherol (vitamin E) have shown antitumor potential by inhibiting metabolic processes in ...

CDR-609 is a T-cell engager therapeutic from CDR-Life Inc. that targets Leucine-rich repeat-containing G protein-coupled ...